Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group.

MLA

Muss, H. B., et al. “Methotrexate in Advanced Endometrial Carcinoma. A Phase II Trial of the Gynecologic Oncology Group.” American Journal of Clinical Oncology, vol. 13, no. 1, Feb. 1990, pp. 61–63. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2407104&authtype=sso&custid=ns315887.

APA

Muss, H. B., Blessing, J. A., Hatch, K. D., Soper, J. T., Webster, K. D., & Kemp, G. M. (1990). Methotrexate in advanced endometrial carcinoma. A phase II trial of the Gynecologic Oncology Group. American Journal of Clinical Oncology, 13(1), 61–63.

Chicago

Muss, H B, J A Blessing, K D Hatch, J T Soper, K D Webster, and G M Kemp. 1990. “Methotrexate in Advanced Endometrial Carcinoma. A Phase II Trial of the Gynecologic Oncology Group.” American Journal of Clinical Oncology 13 (1): 61–63. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=2407104&authtype=sso&custid=ns315887.